Apollomics Inc.
closedW=S@11.50
APLM
Capital Structure & Economics
Trust SizeN/A
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%
Implied Equity Architecture
| Public Trust Allocation | N/A |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $10.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedJun 9, 2023
SearchingTarget Pending
Maturation Wall
Mar 29, 2023
Announced Target / M&A
- Target CompanyApollomics Inc.
- SectorBiopharmaceuticals
- Announced Deal Size$899,000,000
Board & Officers
- Dr. Guo-Liang YuCEO
- Dr. Sanjeev RedkarDirector
- Dr. Lijuan Jane WangDirector
- Dr. Kin-Hung Peony YuDirector
- Dr. Kenneth C. CarterDirector
- Dr. Hong-Jung (Moses) ChenDirector
- Wendy HayesDirector
- Glenn S. VraniakDirector
- Dr. Jonathan WangDirector
Advanced Structuring Terms
| Target Sectors | Biopharmaceuticals |
Syndicate & Advisors
- Maxpro IPO UnderwriterLEAD
- AUDITOR
- AUDITOR
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.